Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Katata

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Introduction]Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Oncology Letters|July 31, 2024
Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregationKeisuke Kimura, Yosuke Katata, Yuzo Umeda, et al.
Case Reports in Gastroenterology|February 23, 2023
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose ImatinibRyo Katsumata, Yasumasa Monobe, Yosuke Katata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Incidence of Catheter-Related Thrombosis in Patients with Long-Term Indwelling Central Venous Port Who Received Chemotherapies for Unresectable Advanced Digestive Cancers]Hiroaki Tanioka, Motoi Asano, Kento Kawasaki, et al.
BMC Cancer|October 13, 2019
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, et al.
Oncotarget|April 18, 2018
Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profilesYoshiko Mori, Akihiro Nyuya, Kazuya Yasui, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Introduction]Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Oncology Letters|July 31, 2024
Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregationKeisuke Kimura, Yosuke Katata, Yuzo Umeda, et al.
Case Reports in Gastroenterology|February 23, 2023
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose ImatinibRyo Katsumata, Yasumasa Monobe, Yosuke Katata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Incidence of Catheter-Related Thrombosis in Patients with Long-Term Indwelling Central Venous Port Who Received Chemotherapies for Unresectable Advanced Digestive Cancers]Hiroaki Tanioka, Motoi Asano, Kento Kawasaki, et al.
BMC Cancer|October 13, 2019
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, et al.
Oncotarget|April 18, 2018
Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profilesYoshiko Mori, Akihiro Nyuya, Kazuya Yasui, et al.
Pageof 1